Xu K - Search Results

1

Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells.

Sun J, Xu K, Qiu Y, Gao H, Xu J, Tang Q, Yin P. Sun J, et al. Among authors: xu k, xu j. Oncol Rep. 2017 Sep;38(3):1420-1430. doi: 10.3892/or.2017.5826. Epub 2017 Jul 17. Oncol Rep. 2017. PMID: 28731184 Free PMC article.

2

MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor.

Shen K, Liang Q, Xu K, Cui D, Jiang L, Yin P, Lu Y, Li Q, Liu J. Shen K, et al. Among authors: xu k. Biochem Pharmacol. 2012 Aug 1;84(3):320-30. doi: 10.1016/j.bcp.2012.04.017. Epub 2012 May 3. Biochem Pharmacol. 2012. PMID: 22580051

3

miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2.

Xu K, Liang X, Shen K, Cui D, Zheng Y, Xu J, Fan Z, Qiu Y, Li Q, Ni L, Liu J. Xu K, et al. Among authors: xu j. Biochem J. 2012 Sep 1;446(2):291-300. doi: 10.1042/BJ20120386. Biochem J. 2012. PMID: 22676135

4

Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells.

Wei X, Wang G, Li W, Hu X, Huang Q, Xu K, Lou W, Wu J, Liang C, Lou Q, Qian C, Liu L. Wei X, et al. Among authors: xu k. Oncol Rep. 2014 Jan;31(1):335-41. doi: 10.3892/or.2013.2858. Epub 2013 Nov 20. Oncol Rep. 2014. PMID: 24253664

5

Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.

Li Z, Qu L, Zhong H, Xu K, Qiu X, Wang E. Li Z, et al. Among authors: xu k. Oncol Rep. 2014 Apr;31(4):1707-14. doi: 10.3892/or.2014.3050. Epub 2014 Feb 24. Oncol Rep. 2014. PMID: 24573418

6

microRNA-497 inhibits invasion and metastasis of colorectal cancer cells by targeting vascular endothelial growth factor-A.

Qiu Y, Yu H, Shi X, Xu K, Tang Q, Liang B, Hu S, Bao Y, Xu J, Cai J, Peng W, Cao Q, Yin P. Qiu Y, et al. Among authors: xu k, xu j. Cell Prolif. 2016 Feb;49(1):69-78. doi: 10.1111/cpr.12237. Epub 2016 Feb 3. Cell Prolif. 2016. PMID: 26840372 Free PMC article.

7

MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells.

Xu K, Shen K, Liang X, Li Y, Nagao N, Li J, Liu J, Yin P. Xu K, et al. Oncotarget. 2016 Nov 15;7(46):75118-75129. doi: 10.18632/oncotarget.12611. Oncotarget. 2016. PMID: 27738333 Free PMC article.

8

Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin.

Yuan Z, Shi X, Qiu Y, Jia T, Yuan X, Zou Y, Liu C, Yu H, Yuan Y, He X, Xu K, Yin P. Yuan Z, et al. Among authors: xu k. Oncol Rep. 2017 Mar;37(3):1815-1825. doi: 10.3892/or.2017.5410. Epub 2017 Jan 30. Oncol Rep. 2017. PMID: 28184922

9

miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma.

Xu K, Chen G, Qiu Y, Yuan Z, Li H, Yuan X, Sun J, Xu J, Liang X, Yin P. Xu K, et al. Among authors: xu j. Oncotarget. 2017 Mar 28;8(13):21719-21732. doi: 10.18632/oncotarget.15559. Oncotarget. 2017. PMID: 28423513 Free PMC article.

10

Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer.

Yuan ZT, Shi XJ, Yuan YX, Qiu YY, Zou Y, Liu C, Yu H, He X, Xu K, Yin PH. Yuan ZT, et al. Among authors: xu k. Oncotarget. 2017 Jul 18;8(29):48012-48026. doi: 10.18632/oncotarget.18225. Oncotarget. 2017. PMID: 28624793 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,345 results

Search Page

Filters